These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 393789
1. Pentoxifylline -- a biomedical profile. Müller R. J Med; 1979; 10(5):307-29. PubMed ID: 393789 [Abstract] [Full Text] [Related]
2. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy. Müller R, Schröer R. J Med; 1979; 10(5):347-64. PubMed ID: 393790 [Abstract] [Full Text] [Related]
3. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline. Müller R, Lebrach F. Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492 [Abstract] [Full Text] [Related]
4. Hemorheology and peripheral vascular diseases: a new therapeutic approach. Müller R. J Med; 1981; 12(4):209-35. PubMed ID: 7031157 [Abstract] [Full Text] [Related]
5. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. Ehrly AM. J Med; 1979; 10(5):331-8. PubMed ID: 294470 [No Abstract] [Full Text] [Related]
6. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. J Med; 1988; 19(2):89-107. PubMed ID: 3049876 [Abstract] [Full Text] [Related]
7. The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review. Schönharting M, Musikić P, Müller R. Pharmatherapeutica; 1988; 5(3):159-69. PubMed ID: 3283776 [Abstract] [Full Text] [Related]
8. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders]. Strano A, Davì G, Novo S, Avellone G, Pinto A. Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117 [No Abstract] [Full Text] [Related]
9. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain]. Eninia GI, Egere DA, Robule VKh, Maĭore IKh. Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):50-2. PubMed ID: 3953193 [Abstract] [Full Text] [Related]
10. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Strano A, Davi G, Avellone G, Novo S, Pinto A. Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350 [Abstract] [Full Text] [Related]
11. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects. Reilly DT, Quinton DN, Barrie WW. N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188 [Abstract] [Full Text] [Related]
12. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability]. Pilla G, Ciaponi A, Migliavacca A, Bonora C. Ric Clin Lab; 1983 Jul 22; 13 Suppl 3():459-64. PubMed ID: 6324325 [Abstract] [Full Text] [Related]
13. Pentoxifylline--a new drug for the treatment of intermittent claudication. Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Indian Heart J; 1989 Jul 22; 41(2):127-33. PubMed ID: 2744799 [Abstract] [Full Text] [Related]